CIK 0000728387
- Non-accelerated filer
- Smaller reporting company
Perspective Therapeutics, Inc.
Sign in to watch- Ticker
- CATX
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 411458152
- Phone
- +1 206-676-0900
- Business address
- 2401 ELLIOTT AVENUE, SUITE 320, SEATTLE, WA, 98121
- Former names
- IsoRay, Inc., Isoray, Inc., CENTURY PARK PICTURES CORP
- 4 Open-market buy Director bought 30,031 shares at an average $1.33 ($40,014)
- 4 Option exercise VP Finance/Prin Fin&Acct Offic acquired 30,000 shares (option exercise)
- 4 Open-market buy 10% owner bought 60,431,039 shares at $0.95 ($57,409,487)
- 4 Open-market buy Director bought 127,206 shares at an average $0.71 ($90,710)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 135,879 shares at an average $0.58 ($78,474)
- 4 Open-market buy Chief Medical Officer bought 280,000 shares at $0.50 ($139,888)
- 4 Open-market buy Director bought 51,996 shares at $0.49 ($25,478)
- 4 Open-market buy Director bought 3,663 shares at $0.33 ($1,203)
- 4 Open-market buy Chief Financial Officer bought 125,000 shares at $0.26 ($32,338)
- 4 Open-market buy Director bought 23,680 shares at an average $0.29 ($6,978)
- 4 Open-market buy Chief Medical Officer bought 595,425 shares at an average $0.32 ($188,737)
- 4 Open-market buy Director bought 185,200 shares at an average $0.27 ($49,989)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 4 of 17 · 339 filings